Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Cancer Research

• Publication date

  2015-08-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-15-0189PMID 26248648PMCID PMC4828339
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translational value of mouse models in oncology drug development

  2015cited by this paper
• A resource for cell line authentication, annotation and quality control

  2015cited by this paper
• Prioritizing therapeutic targets using patient-derived xenograft models.

  2015cited by this paper
• Stromal contribution to the colorectal cancer transcriptome

  2015cited by this paper
• Prognostic stromal gene signatures in breast cancer

  2015cited by this paper
• Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

  2014cited by this paper
• 3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer

  2014cited by this paper
• Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.

  2014cited by this paper
• Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

  2014cited by this paper
• A community effort to assess and improve drug sensitivity prediction algorithms

  2014cited by this paper
• High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

  2014cited by this paper
• A community computational challenge to predict the activity of pairs of compounds

  2014cited by this paper
• A comprehensive transcriptional portrait of human cancer cell lines

  2014cited by this paper
• Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?

  2014cited by this paper
• The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

  2014cited by this paper
• Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.

  2014influential reference
• A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells

  2014cited by this paper
• Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

  2014cited by this paper
• Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection

  2014influential reference
• Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

  2014cited by this paper
• Dynamic DNA methylation across diverse human cell lines and tissues

  2013cited by this paper
• Inconsistency in large pharmacogenomic studies

  2013cited by this paper
• An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

  2013cited by this paper
• A colorectal cancer classification system that associates cellular phenotype and responses to therapy

  2013cited by this paper
• Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

  2013cited by this paper
• The Cancer Genome Atlas Pan-Cancer analysis project

  2013cited by this paper
• The Cancer Genome Atlas Pan-Cancer analysis project

  2013cited by this paper
• Evaluating cell lines as tumour models by comparison of genomic profiles

  2013influential reference
• Modeling precision treatment of breast cancer

  2013influential reference
• Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer

  2012cited by this paper
• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

  2012influential reference
• Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.

  2012cited by this paper
• Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

  2012cited by this paper
• ATM and MET kinases are synthetic lethal with non-genotoxic activation of p53

  2012cited by this paper
• Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells.

  2012cited by this paper
• Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

  2012cited by this paper
• An Integrated Encyclopedia of DNA Elements in the Human Genome

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012influential reference
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment.

  2011cited by this paper
• Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy

  2011cited by this paper
• Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

  2011cited by this paper
• Subtype and pathway specific responses to anticancer compounds in breast cancer

  2011influential reference
• Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

  2010influential reference
• Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft

  2010influential reference
• Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM

  2010cited by this paper
• Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anti-cancer drug activity

  2010cited by this paper
• CellMiner: a relational database and query tool for the NCI-60 cancer cell lines

  2009cited by this paper
• Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

  2009cited by this paper
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009cited by this paper
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

  2009cited by this paper
• Supervised risk predictor of breast cancer based on intrinsic subtypes.

  2009cited by this paper
• Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

  2009influential reference
• A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro.

  2009cited by this paper
• Modeling genomic diversity and tumor dependency in malignant melanoma.

  2008cited by this paper
• Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.

  2008cited by this paper
• 2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells

  2008cited by this paper
• Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.

  2007cited by this paper
• Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

  2007cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

  2007cited by this paper
• The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

  2007cited by this paper
• A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

  2007cited by this paper
• Engineering tumors with 3D scaffolds

  2007cited by this paper
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

  2007cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

  2006cited by this paper
• The NCI60 human tumour cell line anticancer drug screen

  2006influential reference
• Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells.

  2006cited by this paper
• Genetic clonal diversity predicts progression to esophageal adenocarcinoma

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.

  2005cited by this paper
• Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

  2005cited by this paper
• Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

  2004cited by this paper
• Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR

  2004cited by this paper
• The ENCODE (ENCyclopedia Of DNA Elements) Project

  2004cited by this paper
• Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

  2003cited by this paper
• Karyotypic complexity of the NCI-60 drug-screening panel.

  2003influential reference
• A systematic profile of DNA methylation in human cancer cell lines.

  2003cited by this paper
• Integrated classification of lung tumors and cell lines by expression profiling

  2002cited by this paper
• A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines

  2002cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

  1999cited by this paper
• Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

  1999influential reference
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Integrating genetic approaches into the discovery of anticancer drugs.

  1997cited by this paper
• Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

  1996cited by this paper
• Genetic instability induced by the tumor microenvironment.

  1996influential reference
• Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

  1989cited by this paper
• Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts.

  1981cited by this paper

• Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions.

  2026cites this paper
• Current State-of-the-Art Animal Models of Pediatric Brain Tumors

  2025cites this paper
• Challenges and opportunities for oncology drug repurposing informed by synthetic lethality

  2025cites this paper
• Establishment and characterization of NCC-PS2-C1: a novel cell line of high-grade pleomorphic spindle cell sarcoma, most consistent with myxofibrosarcoma

  2025cites this paper
• Establishment and characterization of NCC-SFT1-C1: a novel patient-derived cell line of solitary fibrous tumor

  2025influential citation
• Generation of patient-derived sarcoma organoids for personalized drug screening and precision cancer immunotherapy.

  2025cites this paper
• Toxicity assessment of airborne ultrafine particles: Role of transport emissions.

  2025cites this paper
• Celebrating World Cancer Day: Innovative Biological Approaches to Cancer and their Alignment with Sustainable Development Goals (SDGs)

  2025cites this paper
• Intraline genomic heterogeneity of the triple-negative breast cancer MDA-MB-231-luc-GFP cell line

  2025cites this paper
• Dual-Dynamic Covalently Cross-Linked Polyglycerol Hydrogels for Tumor Spheroid Culture

  2025cites this paper
• A Roadmap for the Future of Systems Biology in Cancer Research.

  2025cites this paper
• High-Resolution aCGH Analysis of the Jurkat Cell Line: Copy Number Alterations and Their Association With Cancer Hallmarks

  2025cites this paper
• From 3D culture to clinical decision-making: Systematic innovations in breast cancer organoids.

  2025cites this paper
• Benzoates host–guest complexation with cationic biguanide cobalt(III) receptor: Enhanced antimicrobial and anticancer activities

  2025cites this paper
• Advances and Challenges in Human 3D Solid Tumor Models

  2025cites this paper
• Validation of In Vitro Model of Oral Fibrosis Via Genetic and Protein Characterization

  2025cites this paper
• Study Models for Chlamydia trachomatis Infection of the Female Reproductive Tract

  2025cites this paper
• Sex Differences in Cancer Functional Genomics: Gene Dependency and Drug Sensitivity

  2025cites this paper
• Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical management

  2024cites this paper
• Plant Based Extract Oil-Based Nano emulsions: Impact on Human Melanoma Cell Line

  2024cites this paper
• Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1

  2024cites this paper
• Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients

  2024cites this paper
• Trust me if you can: a survey on reliability and interpretability of machine learning approaches for drug sensitivity prediction in cancer

  2024cites this paper
• Integrating Multi-Omics Using Bayesian Ridge Regression with Iterative Similarity Bagging

  2024cites this paper
• Design of potent tyrosinase inhibiting N-arylated-4-yl-benzamides bearing 2-aminothiazole-triazole bi-heterocycles: mechanistic insight through enzyme inhibition, kinetics and computational studies

  2024cites this paper
• Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation

  2024cites this paper
• Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines

  2024cites this paper
• Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone

  2024cites this paper
• Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data.

  2024cites this paper
• Integrating analysis of proteome profile and drug screening identifies therapeutic potential of MET pathway for the treatment of malignant peripheral nerve sheath tumor

  2023cites this paper
• Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis

  2023cites this paper
• Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation

  2023cites this paper
• Dermatan Sulfate/Chitosan Nanoparticles Loaded with an Anti-Inflammatory Peptide Increase the Response of Human Colorectal Cancer Cells to 5-Fluorouracil.

  2023cites this paper
• Pioneering models of pediatric brain tumors

  2023cites this paper
• Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

  2023cites this paper
• Pan-Cancer Drug Response Prediction Using Integrative Principal Component Regression

  2023cites this paper
• Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation

  2023cites this paper
• Breast Cancer Organoids Derived from Patients: A Platform for Tailored Drug Screening.

  2023cites this paper
• Inhibitory Effect of Phosphorothioate Oligonucleotide Complementary to G6PD mRNA on Murine Melanoma

  2023cites this paper
• Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction

  2023cites this paper
• A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer

  2023cites this paper
• Establishment of papillary thyroid cancer organoid lines from clinical specimens

  2023cites this paper
• Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibiting moderate effect on normal stem cells growth

  2023cites this paper
• Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth

  2023cites this paper
• Proteomic strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources.

  2023cites this paper
• Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model

  2023influential citation
• Dynamics and specificities of T cells in cancer immunotherapy

  2023cites this paper
• Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin.

  2023cites this paper
• Predicting Drug Response on Multi-Omics Data Using a Hybrid of Bayesian Ridge Regression with Deep Forest

  2023cites this paper
• Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.

  2022cites this paper
• Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma

  2022cites this paper
• Utilization of Cancer Cell Line Screening to Elucidate the Anticancer Activity and Biological Pathways Related to the Ruthenium-Based Therapeutic BOLD-100

  2022cites this paper
• [Cell cultures of human CNS tumors as in vitro model for individualized therapeutic approach].

  2022cites this paper
• Exploration of anticancer potential of Lantadenes from weed Lantana camara: Synthesis, in silico, in vitro and in vivo studies.

  2022cites this paper
• Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma

  2022cites this paper
• Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma

  2022cites this paper
• Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors

  2022cites this paper
• Opportunities for pharmacoproteomics in biomarker discovery

  2022cites this paper
• Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

  2022cites this paper
• CREAMMIST: an integrative probabilistic database for cancer drug response prediction

  2022cites this paper
• Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy

  2022cites this paper
• NetCellMatch: Multiscale Network‐Based Matching of Cancer Cell Lines to Patients Using Graphical Wavelets

  2022cites this paper
• Evolution of precision oncology-guided treatment paradigms.

  2022cites this paper
• Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

  2022cites this paper
• Patient-derived cancer models: Valuable platforms for anticancer drug testing

  2022cites this paper
• Integrative signatures of signaling pathway response increase robustness and accuracy of pathway predictions

  2022cites this paper
• Combined Application of Patient-Derived Cells and Biomaterials as 3D In Vitro Tumor Models

  2022cites this paper
• Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone

  2022cites this paper
• The role of YAP in the control of the metastatic potential of oral cancer

  2022cites this paper
• BaySyn: Bayesian Evidence Synthesis for Multi-system Multiomic Integration

  2022cites this paper
• Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells

  2022cites this paper
• Pharmacogenomic Cluster Analysis of Lung Cancer Cell Lines Provides Insights into Preclinical Model Selection in NSCLC

  2022cites this paper
• Phosphoproteomic Analysis of Breast Cancer-Derived Small Extracellular Vesicles Reveals Disease-Specific Phosphorylated Enzymes

  2022cites this paper
• Mapping oncogenic protein interactions for precision medicine

  2022cites this paper
• Crystal structure, Hirshfeld surfaces and energy framework studies of a biologically active compound (3E)-3-(2,3,4-trimethoxyphenyl) methylidene)-2,3-dihydro-4H-1-benzopyran-4-one

  2022cites this paper
• Cell Culture-Based Assessment of Toxicity and Therapeutics of Phytochemical Antioxidants

  2022cites this paper
• Immuno-oncology trends: preclinical models, biomarkers, and clinical development

  2022cites this paper
• Impact of Washing Processes on RNA Quantity and Quality in Patient-Derived Colorectal Cancer Tissues

  2022cites this paper
• Single-cell RNA sequencing reveals the existence of pro-metastatic subpopulation within a parental B16 murine melanoma cell line.

  2022cites this paper
• Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel

  2022cites this paper
• RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

  2022cites this paper
• LACE: Inference of cancer evolution models from longitudinal single-cell sequencing data

  2021cites this paper
• Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression

  2021cites this paper
• A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization.

  2021cites this paper
• Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors

  2021cites this paper
• Exploiting convergent evolution to derive a pan-cancer cisplatin sensitivity gene expression signature

  2021cites this paper
• Cell Culture Systems for Assessing Toxicity and Chemotherapeutic Potential of Phytochemical Antioxidants

  2021cites this paper
• Tissue biobanks

  2021cites this paper
• Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular Profiles

  2021cites this paper
• Increasing Accuracy of In Vitro Cancer Models: Engineering Stromal Complexity into Tumor Organoid Platforms

  2021cites this paper
• Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma

  2021cites this paper
• Hyperphosphorylation of HDAC2 promotes drug resistance in a novel dual drug resistant mouse melanoma cell line model: an in vitro study.

  2021cites this paper
• Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated Liposarcoma

  2021cites this paper
• Patient Informed Domain Adaptation Improves Clinical Drug Response Prediction

  2021cites this paper
• Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

  2021cites this paper
• Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma

  2021cites this paper
• MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes

  2021cites this paper
• Exploring the Biological Activity and Mechanism of Xenoestrogens and Phytoestrogens in Cancers: Emerging Methods and Concepts

  2021cites this paper
• Experimental Design of Preclinical Experiments: Number of PDX Lines versus Subsampling within PDX Lines.

  2021cites this paper
• Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma

  2021cites this paper